Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Co-Inhibition of IL-2, IL-9 and IL-15 By the Novel Immunomodulator, Bnz-1, Provides Clinical Efficacy in Patients with Refractory Cutaneous T Cell Lymphoma in a Phase 1/2 Clinical Trial

Christiane Querfeld, MDPhD, Basem M. William, MDMRCP, Lubomir Sokol, MD PhD, Oleg Akilov, MD, Brian Poligone, MD PhD, Jasmine Zain, MD, Yutaka Tagaya, MD PhD, Nazli Azimi, PhD PharmD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-143135

Published: 2020

Journal Articles

Paired Single Cell RNA and TCR Sequencing Analysis Following PD-L1 Blockade in Cutaneous T-Cell Lymphoma

Christiane Querfeld, MDPhD, Xiwei Wu, PhD, Hanjun Qin, PhD, Chingyu Su, Zhen Han, Steven T. Rosen, MD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-139992

Published: 2020

Journal Articles

The Involvement of STAT/SOCS Signaling in miRNA-Induced T Cell Exhaustion in Cutaneous T-Cell Lymphoma

Zhen Han, Chingyu Su, Renee J. Estephan, BS, Xiwei Wu, PhD, Sung Hee Kil, PhD, Steven T. Rosen, MD, Christiane Querfeld, MDPhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-139091

Published: 2020

Journal Articles

Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression and Gene Expression Profile

Christiane Querfeld, MDPhD, Ni-Chun Tsai, MS, Joycelynne Palmer, PhD, Xochiquetzal U. Martinez, MD, Farah Abdulla, MD, Xiwei Wu, PhD, Steven T. Rosen, MD, Jasmine Zain, MD

Blood (2020) 136 (Supplement 1): 20.

https://doi.org/10.1182/blood-2020-143354

Published: 2020

Journal Articles

Tnfα Promotes an Immunosuppressive Microenvironment in Cutaneous T Cell Lymphoma and Regulates PD-L1 Expression

Emine Gulsen Gunes, PhD, Sung Hee Kil, PhD, Xiwei Wu, PhD, Chingyu Su, Zhen Han, Hanjun Qin, PhD, Ting-Fang He, PhD, Jing Chen, Yukiko Yamaguchi, PhD, Jasmine M. Zain, MD, Farah Abdulla, MD, Saul Priceman, PhD, Mingye Feng, PhD, Peter P. Lee, MD, Steven T. Rosen, MD, Christiane Querfeld, MDPhD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-141070

Published: 2020

Journal Articles

T Cells in CTCL Have an Exhausted Phenotype While Cutaneous Dendritic Cells Display a Normally Activated Mature Phenotype

Christiane Querfeld, MDPhD, Shane A Curran, PhD, Samantha Leung, BS, Patricia L Myskowski, MD, Steven M. Horwitz, MD, Allan C Halpern, MD, James W. Young, MD

Blood (2014) 124 (21): 1695.

https://doi.org/10.1182/blood.V124.21.1695.1695

Published: 2014

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Co-Inhibition of IL-2, IL-9 and IL-15 By the Novel Immunomodulator, Bnz-1, Provides Clinical Efficacy in Patients with Refractory Cutaneous T Cell Lymphoma in a Phase 1/2 Clinical Trial

Paired Single Cell RNA and TCR Sequencing Analysis Following PD-L1 Blockade in Cutaneous T-Cell Lymphoma

The Involvement of STAT/SOCS Signaling in miRNA-Induced T Cell Exhaustion in Cutaneous T-Cell Lymphoma

Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression and Gene Expression Profile

Tnfα Promotes an Immunosuppressive Microenvironment in Cutaneous T Cell Lymphoma and Regulates PD-L1 Expression

T Cells in CTCL Have an Exhausted Phenotype While Cutaneous Dendritic Cells Display a Normally Activated Mature Phenotype

Email alerts

ASH Publications

American Society of Hematology

Update search

Co-Inhibition of IL-2, IL-9 and IL-15 By the Novel Immunomodulator, Bnz-1, Provides Clinical Efficacy in Patients with Refractory Cutaneous T Cell Lymphoma in a Phase 1/2 Clinical Trial

Paired Single Cell RNA and TCR Sequencing Analysis Following PD-L1 Blockade in Cutaneous T-Cell Lymphoma

The Involvement of STAT/SOCS Signaling in miRNA-Induced T Cell Exhaustion in Cutaneous T-Cell Lymphoma

Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression and Gene Expression Profile

Tnfα Promotes an Immunosuppressive Microenvironment in Cutaneous T Cell Lymphoma and Regulates PD-L1 Expression

T Cells in CTCL Have an Exhausted Phenotype While Cutaneous Dendritic Cells Display a Normally Activated Mature Phenotype

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only